The present application relates to substituted indazoles, to the use thereof alone or in combinations for treatment and/or prophylaxis of autoimmune disorders, and to the use thereof for production of medicaments for treatment and/or prophylaxis of autoimmune disorders, especially for treatment and/or prophylaxis of arthritides (especially psoriatic arthritis, rheumatoid arthritis, Bekhterev's disease, reactive arthritis, systematic juvenile idiopathie arthritis), systematic lupus erythematosus, multiple sclerosis, psoriasis, atopic dermatitis, allergie eczema and chronicinflammatory bowel disorders (especially Crohn's disease and ulcerative colitis).
